Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-04-04 @ 7:03 PM
Study NCT ID:
NCT07376603
Status:
RECRUITING
Last Update Posted:
2026-01-29
First Post:
2026-01-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
IMRT Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features
Sponsor:
Organization:
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
True
Target Duration:
3 Years
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
Enrollment Type:
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Time Perspective List:
Who Masked List: